BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
Rhea-AI Summary
BrightSpring Health Services (NASDAQ:BTSG) priced a secondary offering of 15,000,000 common shares at $58.75 per share. All shares are sold by existing stockholders, so BrightSpring will not receive proceeds. The offering is expected to close on June 5, 2026, subject to customary conditions.
BrightSpring also authorized a concurrent repurchase of 1,026,694 shares from the underwriter, drawn from the offered shares, at the same price paid by the underwriter to the selling stockholders. The share repurchase is conditioned on, and expected to close with, the offering.
Positive
- All 15,000,000 shares are sold by existing holders, causing no new share dilution
- Company authorized repurchase of 1,026,694 shares in connection with the offering
- Repurchased shares carry no underwriting fees paid to the underwriter
Negative
- Large 15,000,000-share secondary increases public float and selling supply
- Company will use cash to repurchase 1,026,694 shares, reducing liquidity
- Share repurchase depends on successful closing of the secondary offering
News Market Reaction – BTSG
In the Jun 4 session, BTSG declined 5.72%, reflecting a notable negative market reaction. Argus tracked a trough of -2.1% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. Trading volume was very high at 3.5x the daily average, suggesting heavy selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Buybacks,offering Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 02 | Secondary priced | Neutral | -2.2% | Priced 20M-share secondary and concurrent 1.46M-share repurchase at $41.15. |
| Mar 02 | Secondary announced | Neutral | -2.2% | Announced 20M-share secondary and buyback up to 10% or $60M. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior secondary-plus-buyback announcements saw modest declines around -2.24% the next day.
This announcement continues BrightSpring’s pattern of secondary offerings by existing holders paired with concurrent share repurchases. On March 2, 2026, the company disclosed a 20,000,000-share secondary and an authorized repurchase of up to 10% or $60 million, followed by pricing at $41.15 per share. Those events led to a roughly -2.24% move. Alongside this capital-markets activity, recent filings show strong revenue growth, portfolio reshaping, and prior buybacks funded around earlier secondaries.
Key Terms
underwritten secondary offering financial
public offering price financial
book-running manager financial
shelf registration statement regulatory
form s-3 regulatory
preliminary prospectus supplement regulatory
prospectus regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate of 15,000,000 shares of common stock of BrightSpring, at the public offering price of
In addition, the Company has authorized, subject to the completion of the offering, the concurrent purchase from the underwriter, out of the 15,000,000 shares of common stock being sold as part of the secondary public offering, 1,026,694 shares of common stock at a price per share equal to the price per share to be paid by the underwriter to the Selling Stockholders. The underwriter will not receive any underwriting fees for the shares being repurchased by the Company. The closing of the share repurchase is conditioned on, and expected to occur simultaneously with, the closing of the offering. The offering is not conditioned upon the completion of the share repurchase.
Goldman Sachs & Co. LLC is acting as the sole book-running manager for the offering.
A shelf registration statement (including a prospectus) on Form S-3 relating to these securities was filed with the Securities and Exchange Commission on June 10, 2025 and became automatically effective upon filing. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering of these securities will be made only by means of a preliminary prospectus supplement and accompanying prospectus. Copies of the preliminary prospectus supplement and accompanying prospectus for the offering may be obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing Prospectus-ny@ny.email.gs.com.
Forward Looking Statements
The statements contained in this press release that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on BrightSpring’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These expectations, beliefs, and projections are expressed in good faith and BrightSpring believes there is a reasonable basis for them. However, there can be no assurance that these expectations, beliefs, and projections will result or be achieved. Actual results may differ materially from these expectations due to changes in global, regional, or local economic, business, competitive, market, regulatory, and other factors, many of which are beyond BrightSpring’s control. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in BrightSpring’s filings with the SEC under caption “Risk Factors,” including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and subsequent other filings BrightSpring makes with the SEC from time to time. Any forward-looking statement in this press release speaks only as of the date of this release. BrightSpring undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.
Contacts
Investor Relations:
David Deuchler, CFA
Gilmartin Group LLC
ir@brightspringhealth.com
or
Media Contact:
Leigh White
leigh.white@brightspringhealth.com
502.630.7412
